Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
“Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity
For decades, plasma was viewed simply as a life-saving medical resource. Today, it has become something far more powerful: a strategic asset shaping national healthcare security, global trade, and geopolitical influence.
In this issue of Blood and Plasma Pulse, we explore a critical but under-discussed reality:
- Why plasma is no longer just a clinical input, but a tool of national resilience
- How a handful of countries now control the majority of global plasma supply
- What “plasma sovereignty” means for healthcare systems and patient access
- How plasma is influencing international alliances, supply agreements, and policy decisions
As demand for plasma-derived therapies accelerates and supply remains highly concentrated, the question is no longer about who donates plasma but who controls its future.
This edition dives into the emerging concept of Plasma Diplomacy, where healthcare, strategy, economics, and global cooperation intersect through a single biological resource.
Is plasma becoming the next strategic healthcare commodity on the global stage?”
Read full paper here.
Stay updated with Hemostasis Today.
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
-
Nov 29, 2025, 16:38PF4 Antibody Persistence and Long-term Pathogenicity in VITT